Xiaomei Liu

Dr. Xiaomei Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2021 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
CHCan Huang
Can Huang
LPLiping Pan
Liping Pan
XSXiaoli Shen
Xiaoli Shen
HTHuimin Tian
Huimin Tian
LGLu Guo
Lu Guo
XLXiaomei Liu
Xiaomei Liu

1 April 2022 in Ceramics International
Verified
Journal Article
Closed access
CYChunling Yang
Chunling Yang
QRQianhong Ren
Qianhong Ren
XLXiaomei Liu
Xiaomei Liu
YLYi Liu
Yi Liu
Botao ZhangBotao Zhang
Botao Zhang
Hua LiHua Li
Hua Li

15 June 2016 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
JZJin‐Ju Zhang
Jin‐Ju Zhang
JXJing‐Feng Xu
Jing‐Feng Xu
YSYong‐Wei Shen
Yong‐Wei Shen
SMShi‐Jiao Ma
Shi‐Jiao Ma
TZTing‐Ting Zhang
Ting‐Ting Zhang
XLXiaomei Liu
Xiaomei Liu

10 May 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DWDongxin Wang
Dongxin Wang
QZQungang Zhou
Qungang Zhou
XQXiang Qiu
Xiang Qiu
XLXiaomei Liu
Xiaomei Liu
CZchun zhang
chun zhang
Recombinant Adeno-associated virus(rAAV) is currently the most widely used gene delivery vector and has been successfully used in various disease models, benefiting from its low immunogenicity, almost no toxicity, and no reported pathogenicity in humans. However, its low transduction efficiency for primary cells, especially for T lymphocytes, limits its further application in the field of cell therapy. In this study, we optimized the protocol for rAAV6 transduction of primary T cells, significantly improved the expression efficiency of the rAAV6 delivered CAR gene, and successfully generated rAAV6-based CAR-T cells (AAV-CAR-T). The gene expression intensity (mean fluorescence intensity, MFI) of rAAV6 transduced T cells treated with the tyrosine kinase inhibitor, Genistein, was increased 1-3-fold. Moreover, our results showed that rAAV6 efficiently transduced T cells stimulated with OKT3 and the gene expression could be enhanced 3-fold with an OKT3 concentration of 50 ng/mL in the medium. The gene expression intensity of T cells treated with OKT3 together with genistein could be augmented by 7-fold. Based on the above-optimized method, CAR-T cells prepared with rAAV6 showed evident anti-tumor ability both in vitro and in vivo. Our findings established an efficient method for the AAV transduction of T cells and would provide an alternative way for the preparation of CAR-T cells.


12 February 2018 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
JZJinju Zhang
Jinju Zhang
XLXiaomei Liu
Xiaomei Liu
YZYun Zhang
Yun Zhang
ZLZuo Luan
Zuo Luan
YYYinxiang Yang
Yinxiang Yang
CZchun zhang
chun zhang